He, B., Chen, H., Wu, J., Qiu, S., Mai, Q., Zeng, Q., . . . Xu, N. Interleukin-21 engineering enhances CD19-specific CAR-NK cell activity against B-cell lymphoma via enriched metabolic pathways. BMC.
Chicago Style (17th ed.) CitationHe, Bailin, et al. Interleukin-21 Engineering Enhances CD19-specific CAR-NK Cell Activity Against B-cell Lymphoma via Enriched Metabolic Pathways. BMC.
MLA (9th ed.) CitationHe, Bailin, et al. Interleukin-21 Engineering Enhances CD19-specific CAR-NK Cell Activity Against B-cell Lymphoma via Enriched Metabolic Pathways. BMC.
Warning: These citations may not always be 100% accurate.